We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A new report by the Organisation for Economic Cooperation and Development
(OECD) indicates that, in 1998 through 2003, the rise in drug spending in Australia
outpaced growth in healthcare spending.
Advancis Pharmaceutical bought an antibiotic drug from a large pharmaceutical
company last year for $11 million and an oral form of the drug is finally on
the shelves.
AnGes MG announced on June 8 that, in collaboration with MedGel, it has launched
a feasibility study for seeking new applications of NF-kappa B decoy oligo,
a kind of nucleic acid medicine.
UCB Japan announced on June 7 that it has signed an agreement with Korean company
Boryung Pharmaceutical, whereby Boryung will exclusively license to sell in
Korea STOGAR tab. 5 and STOGAR tab. 10, H2 receptor antagonists UCB Japan manufactures
and sells in Japan.
SD Pharmaceuticals (SDP) announced that it launched an out-licensing effort
on its proprietary nano-emulsion formulations for a variety of intravenous drugs
to treat cancer and infectious disease.
Sogo Clinical Pharmacology announced on June 7 that it has reached a basic agreement
with SRL and Japan Clinical Pharmacology Laboratories (JCPL), SRL's wholly owned
subsidiary, to acquire JCPL as a subsidiary.
An Aberdeen-based biotech company
that is playing a critical role in developing treatments for chronic diseases
is being closed down by its Frankfurt-based parent, the pharmaceutical giant
Merck. Biovation, based at the Aberdeen Science & Technology Park, is involved
in the development of drugs that could revolutionise the treatment of arthritis.
Healthcare issues are increasingly important in Kuwait's public life,
and the ongoing transition process in the country's healthcare sector has led
to recent controversy.
According to local media reports in Ecuador, the South American nation's drug
market expanded nearly 8% to US$394.8mn in January through November 2004.